NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-275-2002-1-US-06 Immunotherapy With In Vitro-Selected Antigen-Specific Lymphocytes After Nonmyeloablative Lymphodepleting Chemotherapy US DIV 13/178,644 8287857 Expired PDF
NHGRI E-187-2011-0-US-01 METHODS FOR DETECTING ADHD SUSCEPTIBILITY AND PREDICTING SEVERITY AND LONG TERM OUTCOME OF ADHD SYMPTOMS US 61/505,864 Abandoned
NCI E-321-2003-0-US-08 Human Cytotoxic T-Lymphocyte Epitope And It's Agonist Epitope From The Non-Variable Number of Tandem Repeat Sequence of MUC-1 US DIV 13/176,341 8957192 Issued PDF
NCI E-249-2005-0-US-05 Treating Renal Cancer Using A 4-[BIS[2-[(Methylsulfonyl)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE US CON 13/176,129 8273797 Abandoned PDF
NHLBI E-114-2010-0-PCT-02 Active Adaptive Detuning Systems And Methods For Interventional MRI Devices PCT PCT PCT/US2011/042746 Expired
NHGRI E-209-2011-0-US-01 ACSF3 Mutations in Metabolic Disorders7/1/2012 US 61/504,030 Abandoned
NHGRI E-116-2011-0-US-01 Method of Treating Pathologic Heterotopic Ossification (HO) US 61/504,041 Abandoned
NIAID E-219-2014-0-US-01 Compounds For Inhibiting 1-Deoxy-D-Xylulose-5-Phosphate Reductoisomerase US 61/503,736 Abandoned
NCI E-194-2008-0-US-03 Immunotoxins And Uses Thereof US National Stage 12/996,138 Abandoned
NIBIB E-118-2010-0-PCT-02 System and Method of Producing Nondiffracting Light Sheets By A Multiplicity Of Spatially Overlapping, Minimally Interfering Nondiffracting Optical Beams PCT PCT PCT/US2011/042495 Abandoned
NIAID E-213-2010-2-PCT-01 HIV Immunogens PCT PCT COMB PCT/US2011/042434 Expired
NEI E-092-2010-0-EP-05 Methods of Treatment Using Sterculic Acid EP National Stage 11731200.9 Abandoned
NEI E-092-2010-0-FR-08 Methods of Treatment Using Sterculic Acid FR EP 11731200.9 Abandoned
NEI E-092-2010-0-DE-07 Methods of Treatment Using Sterculic Acid DE EP 11731200.9 Abandoned
NEI E-092-2010-0-GB-09 Methods of Treatment Using Sterculic Acid GB EP 11731200.9 Abandoned
NEI E-092-2010-0-AU-03 Methods of Treatment Using Sterculic Acid AU National Stage 2011270754 Abandoned
NEI E-092-2010-0-PCT-02 Methods of Using Sterculic Acid PCT PCT PCT/US2011/041766 Expired
CC E-078-2005-0-US-01 Electrically Conductive Catheter That Inhibits Biological Barrier Formation US 61/501,065 Abandoned
NIAID E-057-2011-1-US-01 VIRUS-LIKE PARTICLES AND METHODS OF USE US 61/501,012 Abandoned
NEI E-092-2010-0-CA-04 Methods of Using Sterculic Acid CA National Stage 2803923 Abandoned
NCI E-100-2010-0-PCT-02 REGULATION OF SKIN PIGMENTATION BY NEUREGULIN-1 (NRG-1) PCT PCT PCT/US2011/041610 Expired
NCI E-159-2011-1-US-01 Novel Chalcone Derivative As Potent Activator Of Nrf2 Signaling US 61/500,272 Abandoned
NIAID E-323-2005-2-AU-11 Influenza Hemagglutinin And Neuraminidase Variants AU DIV 2011202991 Abandoned
NCI E-196-2011-1-US-01 Use of Frizzled Receptor Expression In Measuring Effect of SFRP on WNT/BETA-CATENIN Signaling US 61/499,684 Abandoned
NINDS E-251-2005-0-DE-15 Systems for recovery of motor control via stimulation to a substitute site for an affected area DE EP 11005014.3 Issued
NINDS E-251-2005-0-FR-16 Systems for recovery of motor control via stimulation to a substitute site for an affected area FR EP 11005014.3 Issued
NINDS E-251-2005-0-GB-17 Systems for recovery of motor control via stimulation to a substitute site for an affected area GB EP 11005014.3 Issued
NINDS E-251-2005-0-CH-14 Systems for recovery of motor control via stimulation to a substitute site for an affected area CH EP 11005014.3 Issued
NCI E-183-2010-0-EP-05 Compositions and Methods For Treating Inflammatory Conditions EP National Stage 11731584.6 Abandoned
NCI E-183-2010-0-JP-06 Compositions and Methods For Treating Inflammatory Conditions JP National Stage 2013-515561 Abandoned
NCI E-183-2010-0-PCT-02 Compositions and Methods For Treating Inflammatory Conditions PCT PCT PCT/US2011/040952 Expired
NCI E-201-2010-0-PCT-02 Immunogenic Compsitions Derived From Structural Alteration of HIV Envelope Proteins PCT PCT PCT/US11/040887 Expired
NCI E-183-2010-0-CA-04 Compositions and Methods For Treating Inflammatory Conditions CA National Stage 2802994 Abandoned
NCI E-183-2010-0-AU-03 Compositions and Methods For Treating Inflammatory Conditions AU National Stage 2011268146 Abandoned
NICHD E-201-2011-0-US-01 PEPTIDE PREDICTORS FOR PARAGANGLIOMA AND PHEOCHROMOCYTOMA US 61/498,428 Abandoned
NCI E-025-2009-0-NZ-09 Ratio Based Biomarkers And Methods of Use Thereof NZ National Stage 593514 Issued
NCI E-026-2011-0-PCT-02 Diagnosis And Treatment Of Adrenocortical Tumors Using Human MicroRNA-483 PCT PCT PCT/US2011/040648 Expired
NIAID E-323-2005-3-US-09 Influenza Hemagglutinin And Neuraminidase Varians US DIV 13/161,938 Abandoned
NCI E-158-2010-0-EP-04 ANTI-DR4 AGONIST ANTIBODIES EP National Stage 11796455.1 Abandoned
NCI E-158-2010-0-PCT-02 ANTI-DR4 AGONIST ANTIBODIES PCT PCT PCT/US2011/040750 Expired
NCI E-158-2010-0-CA-03 ANTI-DR4 AGONIST ANTIBODIES CA National Stage 2802349 Abandoned
NCI E-015-2011-0-US-01 A New Chemical Class Of Antiandrogen For The Treatment Of Castrate-resistant Prostate Cancer US 61/497,129 Abandoned
NCI E-196-2011-0-US-01 Use of Frizzled Receptor Expression in Measuring Effect of SFRP ON WNT/BETA-CATENIN Signaling US 61/497,513 Abandoned
NCI E-024-2011-0-US-01 Conjugates, Antibodies, and Their Use US 61/496,986 Abandoned
NCI E-024-2011-1-US-01 COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING TEMS US 61/496,737 Abandoned
NIDA E-087-2002-0-US-10 Methods For Preventing Or Treating Cardiac Arrhythmia US CON 13/158,791 8450325 Expired PDF
NIDDK E-177-2010-0-PCT-02 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents PCT PCT PCT/US2011/039909 Expired
NIDDK E-177-2010-0-EP-03 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents EP National Stage 11728731.8 Abandoned
NCI E-174-2011-0-US-01 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC T CELL EPITOPES US 61/495,085 Abandoned
NLM E-107-2010-2-US-02 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US National Stage 13/120,861 9115386 Issued PDF